Assenagon Asset Management S.A. Cuts Holdings in USANA Health Sciences, Inc. (NYSE:USNA)

Assenagon Asset Management S.A. cut its position in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 12.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 108,264 shares of the company’s stock after selling 15,744 shares during the quarter. Assenagon Asset Management S.A. owned approximately 0.57% of USANA Health Sciences worth $3,886,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Nordea Investment Management AB raised its position in USANA Health Sciences by 5.7% in the fourth quarter. Nordea Investment Management AB now owns 50,450 shares of the company’s stock worth $1,814,000 after acquiring an additional 2,723 shares during the period. Franklin Resources Inc. raised its position in USANA Health Sciences by 9.2% in the third quarter. Franklin Resources Inc. now owns 21,050 shares of the company’s stock worth $750,000 after acquiring an additional 1,771 shares during the period. Barclays PLC raised its position in USANA Health Sciences by 111.9% in the third quarter. Barclays PLC now owns 27,737 shares of the company’s stock worth $1,052,000 after acquiring an additional 14,647 shares during the period. Geode Capital Management LLC raised its position in USANA Health Sciences by 4.5% in the third quarter. Geode Capital Management LLC now owns 297,120 shares of the company’s stock worth $11,269,000 after acquiring an additional 12,898 shares during the period. Finally, State Street Corp raised its position in USANA Health Sciences by 0.6% in the third quarter. State Street Corp now owns 435,164 shares of the company’s stock worth $16,501,000 after acquiring an additional 2,782 shares during the period. 54.25% of the stock is currently owned by hedge funds and other institutional investors.

USANA Health Sciences Stock Down 0.3 %

NYSE USNA opened at $34.02 on Tuesday. The company’s 50 day moving average is $36.91 and its 200-day moving average is $38.67. USANA Health Sciences, Inc. has a 12-month low of $31.44 and a 12-month high of $52.75. The firm has a market cap of $648.33 million, a P/E ratio of 12.02, a price-to-earnings-growth ratio of 0.91 and a beta of 0.89.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings results on Tuesday, October 22nd. The company reported $0.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.07. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The company had revenue of $200.22 million for the quarter, compared to analyst estimates of $208.45 million. During the same quarter in the previous year, the firm posted $0.59 earnings per share. Equities analysts expect that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Analyst Ratings Changes

USNA has been the topic of several research reports. DA Davidson lifted their price objective on shares of USANA Health Sciences from $35.00 to $38.00 and gave the stock a “neutral” rating in a research report on Thursday, January 2nd. StockNews.com raised shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research report on Saturday, December 28th.

Insider Activity

In related news, Director Gilbert A. Fuller sold 675 shares of the company’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $37.71, for a total transaction of $25,454.25. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.33% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.